SNACSpatial Computing Device with AR/VR for Needle Phobia Exposure Therapy
This study uses a spatial computing device with AR/VR to provide exposure therapy for people with needle phobia. We will assess the treatment's acceptability, feasibility, and any adverse events.
Mixed reality (XR) Exposure Therapy
Treatment Study
Summary
Study start date: May 1, 2026
Actual date on which the first participant was enrolled.This study focuses on needle phobia and Blood-Injection-Injury phobia, fears that can affect children, teens, and adults during medical or surgical procedures involving needles. These fears can cause difficulties in care, affecting a person's ability to participate in or receive necessary treatments. Current treatments for these phobias in children and teens are limited, and using medications to manage needle phobia can lead to additional medical complications without addressing the root cause. The study aims to explore the use of Virtual Reality Exposure Therapy (XRET) in children and teens, as recent advancements in technology, like spatial computing and Mixed Reality devices, may enhance engagement and effectiveness of the treatment. The study will evaluate the effectiveness of XRET for children and teens with needle and Blood-Injection-Injury phobias undergoing procedures at LPCH and Stanford Hospital. Participants will undergo XRET, and the study will measure changes in anxiety symptoms related to these phobias. The study will use a validated tool called the APA severity Measure for Specific Phobia (APA-SMS) to assess symptom severity. This scale ranges from 0 to 40, with higher scores indicating greater phobia severity. A decrease in symptom ratings from moderate, severe, or extreme to mild or none by the end of the treatment indicates remission of symptoms.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 11 to 17 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Lucile Parkard Children's Hospital
Stanford, United StatesOpen Lucile Parkard Children's Hospital in Google Maps